Results 11 to 20 of about 208,152 (156)
Los impactos de género de las políticas de drogas en las mujeres: estudios de casos en México
Revue Internationale de Politique de Développement, 2020 Este trabajo se centra en mujeres acusadas de delitos relacionados con drogas y en mujeres que usan drogas, desde la perspectiva de la intersección de tres ejes: i) las relaciones y los sistemas de género, ii) el desarrollo y iii) las políticas de drogas.
Corina Giacomello
doaj +1 more source
Drug Control and Development: A Blind Spot
Revue Internationale de Politique de Développement, 2020 Development questions have been central to international drug policy since the first tentative steps towards a global control regime over a century ago.
Julia Buxton
doaj +1 more source
The Meaningful Participation of ‘Stakeholders’ in Global Drug Policy Debates—A Policy Comment
Revue Internationale de Politique de Développement, 2020 This policy comment seeks to address three key questions relating to the participation of civil society in international drug policymaking. Firstly, who are the relevant ‘stakeholders’ and what options do they have to participate in drug policy ...
Ann Fordham
doaj +1 more source
Value in Health Regional Issues, 2018 The aim of this article was to present a general overview of the health care system as well as pricing and reimbursement environment in Estonia. In Estonia the main stakeholders in the pharmaceutical sector are the Ministry of Social Affairs, the State Agency of Medicine, and the Estonian Health Insurance Fund.
Kadri, Mägi +2 more
openaire +2 more sources
The World Drug Policy Problem. An Interview with José Ramos-Horta
Revue Internationale de Politique de Développement, 2020 José Ramos-Horta is a former president of Timor-Leste, a Nobel Peace Prize laureate and a current member of the Global Commission on Drug Policy (GCDP). Khalid Tinasti, one of the guest editors of this Thematic Issue, interviewed José Ramos-Horta to gain
José Ramos-Horta, Khalid Tinasti
doaj +1 more source
Value in Health Regional Issues, 2017 We present a brief overview of the health care system in Hungary, focusing particularly on the pricing and reimbursement procedures of medicines. The National Institute of Health Insurance Fund Management is responsible for the administration of the health insurance system and public reimbursement of health technologies.
András, Inotai +3 more
openaire +2 more sources
Revue Internationale de Politique de Développement, 2020 This paper challenges contemporary policy conceptions on the historical relationship between drugs and development policies. It uses a historical analysis to examine the interaction of drugs, governance, security, welfare and economic development ...
John Collins
doaj +1 more source
Making War: Conflict Zones and Their Implications for Drug Policy
Revue Internationale de Politique de Développement, 2020 The illicit drug economy has emerged as a major factor that can exacerbate violence, complicate peace negotiations and corrupt transitions from war to peace.
Tuesday Reitano
doaj +1 more source
The Neo-Patrimonial ‘Use’ of Drug Policy in Electoral Processes
Revue Internationale de Politique de Développement, 2020 The prohibition of illegal drug production, use and trafficking has resulted in several shortcomings and negative consequences for other global development objectives.
Khalid Tinasti
doaj +1 more source
Value in Health Regional Issues, 2017 We present a general overview of the health care system as well as the pricing and reimbursement environment in Latvia. Overall, the pharmaceutical sector in Latvia, including pricing and reimbursement, is strictly regulated. The main Latvian stakeholder in the pharmaceutical sector is the Ministry of Health.
Janis, Silins, Monika, Szkultecka-Dębek
openaire +2 more sources